Corporate Finance

Backed by $7M and AI pioneers, Obin AI emerges from stealth to deploy a trustworthy AI workforce for high-stakes financial decisions.

Dartmouth-based GSTS secures ACOA funding to expand its OCIANA AI platform, enhancing maritime security for NATO and optimizing global supply chains.

A triple win from Black Book Research for IKS Health isn't just a trophy; it's proof that AI is now the backbone of modern healthcare revenue and operations.

With a major Series B financing, Crossbow advances its TCR-mimetic therapies, aiming to unlock a new frontier in the fight against a broad range of cancers.

A new app lets you break apart and manipulate playing video in real time. This free tool from Tokyo's ATLGS is poised to disrupt sports analysis and beyond.

As AI pushes grids to the brink, Exowatt opens a new Texas facility to deploy its modular, clean power solutions, aiming to reshape energy infrastructure.

An 8-14% energy surcharge from a key chemical supplier highlights how the Middle East conflict is driving up industrial costs and disrupting supply chains.

A new report reveals why immediate cash aid is now a crucial employer benefit, as rising costs force workers to raid their 401(k)s for emergencies.

A new AI platform lets developers search for land by what they want to build, bypassing complex zoning codes and promising to accelerate construction.

An Israeli deep-tech firm has launched from stealth with a novel AI platform to solve the energy bottleneck strangling the global AI revolution.

New data suggests Phanes Therapeutics' bispecific antibody may overcome major side effects of CD47 inhibitors while showing promise in tough GI cancers.

Swiss firm H55's flight-proven batteries are fast-tracking a new hybrid-electric regional aircraft demonstrator, promising a 30% leap in fuel efficiency.

With massive revenue growth but mounting losses, Angel Studios heads to a key investor conference to prove its unique audience-led model is a new Hollywood bible.

A new US-Canadian partnership between UNION and NALAGX aims to use software-driven factories to solve the critical 155mm artillery shell shortage.

A new partnership combines large-scale strategy with clinical AI tech, offering a single path for healthcare systems to deploy AI amid a global staff crisis.

Artelo Biosciences is testing a novel cannabinoid drug for glaucoma, aiming to protect vision in a way current treatments can't—all without diluting shares.

With veteran leader Brian McKelligon at the helm, Infinity Bio aims to commercialize its powerful MIPSA platform and redefine precision medicine.

A new partnership will leverage genetically engineered mice to create novel antibody drugs, potentially unlocking treatments for cancer and brain diseases.

The controversial safety app Citizen is in 15 new cities. It promises real-time alerts but brings a history of privacy concerns and vigilantism fears.

Operator of China's BOSS Zhipin announces a major dividend and buyback plan, signaling deep confidence in its market dominance and future profitability.